Constellation’s founders and scientific advisors are pioneers, authorities and thought leaders within the fields of epigenetics, drug discovery, and clinical medicine. They have made innumerable contributions to our understanding of epigenetic biology and to the development of novel therapeutics.


Danny Reinberg, Ph.D.

Terry and Mel Karmazin Professor, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine
Howard Hughes Medical Institute Investigator
Member of the National Academy of Sciences

David Allis, Ph.D.

Joy and Jack Fishman Professor and Head of the Laboratory of Chromatin Biology and Epigenetics at The Rockefeller University
Member of the National Academy of Sciences

Yang Shi, Ph.D

Professor of Cell Biology, HMS and Merton Bernfield Professor of Neonatology at Children’s Hospital

Scientific Advisory Board

David Livingston, M.D.

Deputy Director, Dana Farber Harvard Cancer Center
Professor of Medicine and Genetics, Harvard Medical School

Scott Lowe, Ph.D.

Chair of the Geoffrey Beene Cancer Research Center
Cancer Biology and Genetics Program, Sloan-Kettering Institute
Howard Hughes Medical Institute

Robert Schreiber, Ph.D.

Alumni Endowed Professor of Pathology and Immunology
Professor of Molecular Microbiology
Director of the Center for Human Immunology and Immunotherapy programs, Washington University School of Medicine

Padmanee Sharma, M.D., Ph.D.

Professor, Department of Genitourinary Medical Oncology, Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Constellation Pharmaceuticals, Inc.
215 First Street, Suite 200
Cambridge, MA 02142

For Media Inquiries
Katie Engleman
+1 (910) 509-3977

For General Inquires
To request additional information please use:
Phone: (617) 714-0555
Fax: (617) 577-0472